Cargando…
TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway
P-glycoprotein (P-gp) acts as a pump to transport cytotoxic drugs out of cells and is upregulated in cancer cells. Suppressing the expression of P-gp is an effective strategy to overcome multidrug resistance in cancer chemotherapy. Temozolomide (TMZ) is the recommended drug for the standard treatmen...
Autores principales: | Zou, Yan, Liu, Zi'xiang, Zhou, Yi'nan, Wang, Jing, Xu, Qin'yi, Zhao, Xu'dong, Miao, Zeng'li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427319/ https://www.ncbi.nlm.nih.gov/pubmed/34500231 http://dx.doi.org/10.1016/j.tranon.2021.101214 |
Ejemplares similares
-
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth()()
por: Towner, Rheal A., et al.
Publicado: (2018) -
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
por: Kao, Tzu-Jen, et al.
Publicado: (2023) -
Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma
por: Yuan, Fanen, et al.
Publicado: (2022) -
Gasdermin D Is a Novel Prognostic Biomarker and Relates to TMZ Response in Glioblastoma
por: Liu, Junhui, et al.
Publicado: (2021) -
Enhanced Sensitivity to ALDH1A3-Dependent Ferroptosis in TMZ-Resistant Glioblastoma Cells
por: Wu, Yang, et al.
Publicado: (2023)